Search Within

Viktoriya Paroder

  1. "Gastrointestinal Oncology Service"
Formats
  1. Journal Article (16)
  2. Meeting Abstract (8)
  3. Review (1)
Groups
  1. Body Imaging Service (25)
  2. Department of Medicine (25)
  3. Gastrointestinal Oncology Service (25)
  4. Radiology, Department of (25)
  5. Solid Tumor Oncology Division (25)
  6. GSK Faculty (15)

More Groups

People
  1. Yelena Janjigian (11)
  2. Geoffrey Ku (10)
  3. Joanne Chou (9)
  4. Marinela Capanu (9)
  5. Steven Maron (9)
  6. Jinru Shia (7)

More People

Years
  1. 2024 (3)
  2. 2023 (4)
  3. 2022 (7)
  4. 2021 (4)
  5. 2020 (3)
  6. 2019 (3)

More Years

Publications
  1. Journal of Clinical Oncology (5)
  2. Journal of Gastrointestinal Oncology (5)
  3. Annals of Oncology (2)
  4. Journal of Nuclear Medicine (2)
  5. American Journal of Roentgenology (1)
  6. Cancer Research (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (7)
  2. Pioneer Bioscience Publishing Company (5)
  3. American Association for Cancer Research (2)
  4. Oxford University Press (2)
  5. Society of Nuclear Medicine (2)
  6. AME Publishing Company (1)

More Publishers

Results (25)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pembrolizumab with trastuzumab and chemotherapy (PTC) in HER2-positive metastatic esophagogastric cancer (mEG): Plasma and tumor-based biomarker analysis
    Meeting Abstract

    Maron, S. B.; Chatila, W. K.; Millang, B. M.; Sabwa, S.; Chou, J. F.; Ling, L.; Nagy, R.; Simmons, M.; Do, R. K. G.; Paroder, V.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • ARAF activates RAS by antagonizing its interaction with NF1
    Meeting Abstract

    Su, W.; Yaeger, R.; Na, N.; Hechtman, J.; Paroder, V.; Misale, S.; Han, S. W.; Abdel-Wahab, O. I.; McCormick, F.; Rosen, N.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Maximizing response: A case report of salvage chemotherapy after immune checkpoint inhibition in a patient with previous chemo-refractory metastatic esophageal carcinoma
    Journal Article

    Greally, M.; Agarwal, R.; El Dika, I.; Shamseddine, A.; El-Olayan, A.; Haibe, Y.; Paroder, V.; Shia, J.; Abou-Alfa, G. K.; Ku, G. Y.
    Journal of Gastrointestinal Oncology (2019)

    Fulltext@MSK | Save
  • Majority of B2M-mutant and -deficient colorectal carcinomas achieve clinical benefit from immune checkpoint inhibitor therapy and are microsatellite instability-high
    Journal Article

    Middha, S.; Yaeger, R.; Shia, J.; Stadler, Z. K.; King, S.; Guercio, S.; Paroder, V.; Bates, D. D. B.; Rana, S.; Diaz, L. A. Jr; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Outcomes for matched patients with metastatic colitis-associated cancers versus sporadic colorectal cancer receiving chemotherapy
    Meeting Abstract

    Yaeger, R.; Hersch, J.; Bates, D.; Paroder, V.; Chou, J. F.; Tang, L. H.; Gollub, M. J.; Capanu, M.; Kelsen, D. P.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save